Novo Nordisk A/S (NYSE: NVO) has announced plans to cut the official list prices of some of its most widely used obesity and diabetes drugs...
Wegovy
Hims & Hers Health, Inc. (NYSE: HIMS) just shook up the weight loss drug market with plans to sell a version of Novo Nordisk’s (NYSE:...
Novo Nordisk A/S (NYSE: NVO, CPH: NOVO-B) opened trading over 9% higher after U.S. regulators cleared an oral version of its weight-loss drug Wegovy. The...
